Parexel Execs On Obesity Drug Hurdles, Parexel GPT, India RWD Opportunity

 
• By Vibha Ravi

Parexel’s chief strategy officer Kushal Gohil, Clinical EVP Stephen Pyke and India head Sanjay Vyas share thoughts on possible hurdles to, and the cascading impact of obesity treatments, GenAI progress and the opportunities and challenges of real-world data in India, in the second of this two-part interview with Scrip.

Parexel's Kushal Gohil, Stephen Pyke, Sanjay Vyas
L to R - Parexel’s Kushal Gohil (chief strategy officer), Sanjay Vyas (EVP and MD for India) and Stephen Pyke (EVP, Clinical Data and Digital Services) • Source: Citeline/Scrip

More from R&D

More from Scrip